1 |
Bhattarai J, Sumerall S. Current and Future Treatment Options for Narcolepsy: A Review. Sleep Sci 2017;10:19-27. [PMID: 28966734 DOI: 10.5935/1984-0063.20170004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
2 |
Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. J Clin Sleep Med 2017;13:441-53. [PMID: 28095967 DOI: 10.5664/jcsm.6500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
3 |
Sykes N, Beirne P, Horowitz A, Jones I, Kalof L, Karlsson E, King T, Litwak H, McDonald RA, Murphy LJ, Pemberton N, Promislow D, Rowan A, Stahl PW, Tehrani J, Tourigny E, Wynne CDL, Strauss E, Larson G. Humanity's Best Friend: A Dog-Centric Approach to Addressing Global Challenges. Animals (Basel) 2020;10:E502. [PMID: 32192138 DOI: 10.3390/ani10030502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
4 |
Aguilar AC, Frange C, Pimentel Filho LH, Reis MJ, Tufik S, Coelho FMS. Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series. Braz J Psychiatry 2020;42:314-6. [PMID: 31859793 DOI: 10.1590/1516-4446-2019-0544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
5 |
Vellieux G, Frija-Masson J, Rouvel-Tallec A, Drouot X, d'Ortho MP. Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nat Sci Sleep 2021;13:1669-73. [PMID: 34594143 DOI: 10.2147/NSS.S311283] [Reference Citation Analysis]
|